<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2909222665
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2003
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TENSOTIN 100 MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ATENOLOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        20.60
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C07AB03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Tensotin</strong> contains a medicine called atenolol. This belongs to a group of medicines called beta-blockers.<strong> Tensotin</strong> is used to:</p><p>&sect; Treat high blood pressure (hypertension).</p><p>&sect; Help prevent chest pain (angina).</p><p>&sect; Treat uneven heart beats (arrhythmias).</p><p>&sect; Protect the heart in the early treatment after a heart attack (myocardial infarction).</p><p>&sect; Help prevent another heart attack from happening.</p><p>It works by making your heart beat more slowly and with less force.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Tensotin:</strong></p><p>&sect; If you are allergic to atenolol or any of the other ingredients of this medicine (listed in section 6.)</p><p>&sect; If you have ever had any of the following heart problems:</p><p>- heart failure which is not under control (this usually makes you breathless and causes your ankles to swell)</p><p>- second- or third-degree heart block (a condition which may be treated by a pacemaker)</p><p>- very slow or very uneven heart beats, very low blood pressure or very poor circulation.</p><p>&sect; &nbsp;If you have a tumour called pheochromocytoma that is not being treated. This is usually near your kidney and can cause high blood pressure.</p><p>&sect; If you have been told that you have higher than normal levels of acid in your blood (metabolic acidosis).</p><p>Do not take <strong>Tensotin</strong> if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking <strong>Tensotin</strong>.</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking <strong>Tensotin</strong>:</p><p>&sect; <strong>If you have asthma, wheezing or any other similar breathing problems, or you get allergic reactions, for example to insect stings. If you have ever had asthma or wheezing, do not take this medicine without first checking with your doctor.</strong></p><p>&sect; If you have a type of chest pain (angina) called Prinzmetal&#39;s angina.</p><p>&sect; If you have poor blood circulation or controlled heart failure.</p><p>&sect; If you have first-degree heart block.</p><p>&sect; If you have diabetes. Your medicine may change how you respond to having low blood sugar. You may feel your heart beating faster.</p><p>&sect; If you have thyrotoxicosis (a condition caused by an overactive thyroid gland). Your medicine may hide the symptoms of thyrotoxicosis.</p><p>&sect; If you have problems with your kidneys. You may need to have some check-ups during your treatment.</p><p>&sect; If you have psoriasis (a skin condition).</p><p>If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking <strong>Tensotin.</strong></p><p><strong>Other medicines and Tensotin</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines.</p><p>This is because <strong>Tensotin</strong> can affect the way some other medicines work and some medicines can have an effect on <strong>Tensotin</strong>.</p><p><strong>In particular, tell your doctor if you are taking any of the following medicines:</strong></p><p>&sect; Water tablets (diuretics), guanethidine, reserpine or other medicines for high blood pressure.</p><p>&sect; Clonidine (for high blood pressure or migraine). If you are taking clonidine and <strong>Tensotin</strong> together, do not stop taking clonidine unless your doctor tells you to do so. If you have to stop taking clonidine, your doctor will give you careful instructions about how to do it.</p><p>&sect; Verapamil, diltiazem and nifedipine (for high blood pressure or chest pain).</p><p>&sect; Disopyramide, quinidine or amiodarone (for an uneven heart beat).</p><p>&sect; Digoxin (for heart problems).</p><p>&sect; Adrenaline, also known as epinephrine (a medicine that stimulates the heart).</p><p>&sect; Lidocaine, procainamide and noradrenaline, also known as norepinephrine (for heart problems).</p><p>&sect; Ibuprofen or indometacin (for pain and inflammation).</p><p>&sect; Insulin or medicines that you take by mouth for diabetes.</p><p>&sect; Medicines to treat nose or sinus congestion or other cold remedies (including those you can buy in the pharmacy).</p><p><strong>Operations</strong></p><p>If you go into hospital to have an operation, tell the anaesthetist or medical staff that you are taking <strong>Tensotin</strong>. This is because you can get low blood pressure (hypotension) if you are given certain anaesthetics while you are taking <strong>Tensotin</strong>.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>Driving and using machines</strong></p><p>&sect; Your medicine is not likely to affect you being able to drive or use any tools or machines.</p><p>However, it is best to wait to see how your medicine affects you before trying these activities.</p><p>&sect; If you feel dizzy or tired when taking this medicine, do not drive or use any tools or machines.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&sect; Your doctor will tell you how many tablets to take each day and when to take them.</p><p>&sect; Swallow your <strong>Tensotin</strong> tablet whole with a drink of water.</p><p>&sect; Try to take your tablet at the same time each day.</p><p><strong>Adults</strong></p><p>Your doctor will decide how much <strong>Tensotin</strong> you should take each day, depending on your condition. The dose is normally taken once a day.</p><p>&sect; <strong>High blood pressure (hypertension)</strong>: the recommended dose is 50mg to 100mg a day.</p><p>&sect; <strong>Chest pain (angina):</strong> the recommended dose is 50mg to 100mg a day or 50mg twice a day.</p><p>&sect; <strong>Uneven heart beats (arrhythmias</strong>): the recommended dose is 50mg to 100mg a day.</p><p>&sect; <strong>The early treatment of a heart attack</strong> <strong>(myocardial infarction):</strong> the recommended dose is 50mg twice a day. Your doctor may then change this to 100mg once a day.</p><p>&sect; <strong>To help prevent another heart attack:</strong> the recommended dose is 100mg a day.</p><p><strong>Elderly</strong></p><p>If you are an elderly person, your doctor may decide to give you a lower dose, particularly if you have problems with your kidneys.</p><p><strong>People with kidney problems</strong></p><p>If you have severe kidney problems your doctor may decide to give you a lower dose.</p><p><strong>Use in Children</strong></p><p>This medicine must not be given to children.</p><p><strong>If you take more Tensotin than you should</strong></p><p>If you take more <strong>Tensotin</strong> than prescribed by your doctor, talk to a doctor or go to a hospital straight away. Take the medicine pack with you so that the tablets can be identified.</p><p><strong>If you forget to take Tensotin</strong></p><p>If you forget to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop taking Tensotin</strong></p><p>Do not stop taking <strong>Tensotin</strong> even if you are feeling well, without talking to your doctor. Then only do so gradually. Your doctor will tell you how to do this.</p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Allergic reactions:</strong></p><p>If you have an allergic reaction, see a doctor straight away. The signs may include raised lumps on your skin (weals), or swelling of your face, lips, mouth, tongue or throat.</p><p><strong>Other possible side effects</strong>:</p><p><strong>Common (may affect up to 1 in 10 people)</strong></p><p>&sect; You may notice that your pulse rate becomes slower while you are taking the tablets. This is normal but if you are concerned, please tell your doctor about it.</p><p>&sect; Cold hands and feet.</p><p>&sect; Diarrhea.</p><p>&sect; Feeling sick (nausea).</p><p>&sect; Feeling tired.</p><p><strong>Uncommon (may affect up to 1 in 100 people)</strong></p><p>&sect; Disturbed sleep.</p><p><strong>Rare (may affect up to 1 in 1,000 people)</strong></p><p>&sect; Heart block (which can cause abnormal heart beat, dizziness, tiredness or fainting).</p><p>&sect; Numbness and spasm in your fingers which is followed by warmth and pain (Raynaud&rsquo;s disease).</p><p>&sect; Mood changes.</p><p>&sect; Nightmares.</p><p>&sect; Feeling confused.</p><p>&sect; Changes in personality (psychoses) or hallucinations.</p><p>&sect; Headache.</p><p>&sect; Dizziness (particularly when standing up).</p><p>&sect; Tingling of your hands.</p><p>&sect; Being unable to get an erection (impotence).</p><p>&sect; Dry mouth.</p><p>&sect; Dry eyes.</p><p>&sect; Disturbances of vision.</p><p>&sect; Thinning of your hair.</p><p>&sect; Skin rash.</p><p>&sect; Reduced numbers of platelets in your blood (this may make you bruise more easily).</p><p>&sect; Purplish marks on your skin.</p><p>&sect; Jaundice (causing yellowing of your skin or the whites of your eyes).</p><p><strong>Very rare (may affect up to 1 in 10,000 people)</strong></p><p>&sect; Changes to some of the cells or other parts of your blood. Your doctor may take blood samples every so often to check whether <strong>Tensotin</strong> has had any effect on your blood.</p><p><strong>Not known (frequency cannot be estimated from the available data) </strong></p><p>&sect; Lupus-like syndrome (a disease where the immune system produces antibodies that attacks mainly skin and joints).</p><p><strong>Conditions that may get worse</strong></p><p>If you have any of the following conditions, they may get worse when you start to take your medicine. This happens rarely, affecting less than 1 in 1,000 people.</p><p>&sect; Psoriasis (a skin condition).</p><p>&sect; Being short of breath or having swollen ankles (if you have heart failure).</p><p>&sect; Asthma or breathing problems.</p><p>&sect; Poor circulation.</p><p>Do not be concerned by this list of side effects. You may not get any of them.</p><p>&nbsp;</p><p><strong><u>To report any side effect(s):</u></strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:</p><p>&sect; <strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax: </strong>+966-11-205-7662</p><p><strong>Call NPC at </strong>+966-11-2038222<strong>, Exts: </strong>2317-2356-2340</p><p><strong>Reporting Hotline: </strong>19999</p><p><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>Website: </strong>www.sfda.gov.sa/npc</p><p>&sect; <strong>Other GCC States: </strong>Please contact the relevant competent authority.</p><p>By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.</p><p>- Do not take <strong>Tensotin </strong>after the expiry date which is stated on the carton and on the blister.</p><p>- Store below 30&deg;C, in a dry place.</p><p>- Do not take <strong>Tensotin </strong>if you notice any visible sign of deterioration.</p><p>- Medicines should<em> </em>not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is atenolol. Each film-coated tablet contains 100mg of atenolol.</p><p>The other ingredients: Maize starch, magnesium carbonate, sodium lauryl sulphate, cellulose powder, microcrystalline cellulose, &nbsp;sodium starch glycolate, magnesium stearate, hypromellose, polyethylene glycol 4000, talc, titanium dioxide, dispersed orange and FD &amp; C red no. 40.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Tensotin film-coated tablets are available in packs of 30 tablets (3 blisters of 10 tablets each) and hospital packs of 100 tablets. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                
17/06/2020

            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتو<strong>ي تنسوتين </strong>على المادة فعالة أتينولول، التي تنتمي إلى مجموعة من الأدوية تعرف باسم غالقات مستقبلات بيتا.</p><p dir="RTL">يستخدم <strong>تنسوتين</strong> في الحالات التالية:</p><p dir="RTL">&sect;&nbsp; علاج ارتفاع ضغط الدم</p><p dir="RTL">&sect;&nbsp; المساعدة في الحد من حدوث آلام الصدر (الذبحة الصدرية).</p><p dir="RTL">&sect;&nbsp; علاج عدم تكافؤ ضربات القلب (اضطراب نظم ضربات القلب).</p><p dir="RTL">&sect;&nbsp; حماية القلب في مرحلة العلاج المبكر بعد الإصابة بالنوبة القلبية (احتشاء عضلة القلب).</p><p dir="RTL">&sect;&nbsp; المساعدة في الحد من حدوث النوبات القلبية الأخرى.</p><p dir="RTL">يعمل هذا الدواء على تباطؤ ضربات القلب بصورة أكبر وبجهد أقل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم</strong><strong> تناول تنسوتين في الحالات التالية:</strong></p><p dir="RTL">&sect;&nbsp; إذا كنت تعاني من الحساسية تجاه<strong> </strong>أتينولول أو أياً من المكونات الأخرى في هذا الدواء (المذكورة في البند رقم 6)</p><p dir="RTL">&sect;&nbsp; إذا عانيت مسبقاً من أياً من مشاكل القلب التالية:</p><p dir="RTL">-&nbsp; قصور القلب والذي لا يمكن السيطرة عليه (وهذا يجعلك دائماً تشعر بعدم القدرة على التنفس ويسبب تورم في الكاحلين)</p><p dir="RTL">-&nbsp; الإحصار القلبي من الدرجة الثانية أوالثالثة (هي حالة يمكن علاجها عن طريق جهاز تنظيم ضربات القلب)</p><p dir="RTL">-&nbsp; اضطرابات نظم ضربات القلب، انخفاض شديد في ضغط الدم أو بطء في الدورة الدموية.</p><p dir="RTL">&sect;&nbsp; إذا كنت تعاني من ورم يعرف باسم ورم القواتم والذي لم يتم علاجه بعد والذي يكون عادةً بالقرب من الكلى ويسبب ارتفاع في ضغط الدم.</p><p dir="RTL">&sect;&nbsp; إذا تم إخبارك بأنك تعاني من ارتفاع في مستويات الحمض في الدم بصورة أكبر من المعدل الطبيعي (الحماض الأيضي).</p><p dir="RTL">يجب عليك عدم تناول <strong>تنسوتين</strong>، في حال أياً مما ذكر أعلاه ينطبق عليك.<strong> </strong>يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>تنسوتين</strong>، مالم تكن متأكداً من ذلك.</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل<strong> </strong>تناول<strong> تنسوتين </strong>في الحالات التالية:</p><p dir="RTL"><strong>&sect;&nbsp; </strong><strong>إذا كنت تعاني من داء الربو، أزيز أو أي مشاكل أخرى مشابهة في التنفس، أو تعاني من تفاعلات تحسسية، على سبيل المثال لدغ الحشرات. يجب عدم تناول هذا الدواء إلا بعد استشارة طبيبك المعالج أولاً، إذا كنت تعاني من داء الربو أو حدوث أزيز.</strong></p><p dir="RTL">&sect;&nbsp; إذا<strong> </strong>كنت تعاني من إحدى أنواع آلام الصدر (ذبحة صدرية) يعرف باسم ذبحة برنزميتال.</p><p dir="RTL">&sect;&nbsp; إذا<strong> </strong>كنت تعاني من ضعف في الدورة الدموية أو قصور القلب والذي يمكن السيطرة عليه.</p><p dir="RTL">&sect;&nbsp; إذا<strong> </strong>كنت تعاني من الإحصار القلبي من الدرجة الثانية.</p><p dir="RTL">&sect;&nbsp; إذا<strong> </strong>كنت تعاني من داء السكري. قد يعمل الدواء الخاص بك على تغيير مدى استجابتك للدواء الذي يعمل على تقليل مستوى السكر في الدم. قد تشعر بتسارع ضربات القلب.</p><p dir="RTL">&sect;&nbsp; إذا<strong> </strong>كنت تعاني من تسمم الغدة الدرقية (هي حالة مرضية ناتجة عن فرط نشاط الغدة الدرقية). قد يخفي هذا الدواء أعراض تسمم الغدة الدرقية.</p><p dir="RTL">&sect;&nbsp; كنت تعاني من مشاكل في الكلى. قد تحتاج لإجراء فحوصات أثناء فترة العلاج.</p><p dir="RTL">&sect;&nbsp; إذا كنت تعاني من الصدفية (حالية مرضية جلدية)</p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل تناول <strong>تنسوتين،</strong> مالم تكن متأكداً من أن أياً مما ذكر أعلاه ينطبق عليك.</p><p dir="RTL"><strong>تناول الأدوية الأخرى بالتزامن مع تنسوتين</strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول، تناولت مؤخراً أو قد تتناول أية أدوية أخرى، بما في ذلك الأدوية التي تصرف دون وصفة طبية والأعشاب الطبية. وذلك لأنه قد يؤثر <strong>تنسوتين</strong> على آلية عمل بعض الأدوية الأخرى، كما قد تؤثر بعض الأدوية الأخرى على آلية عمل <strong>تنسوتين</strong>.</p><p dir="RTL"><strong>بصفة خاصة، يرجى منك إخبار طبيبك المعالج إذا كنت تتناول أياً من الأدوية التالية:</strong></p><p dir="RTL">&sect;&nbsp; أقراص المدرة للبول، غوانيثيدين، ريزيربين أو أية أدوية أخرى تستخدم لعلاج ارتفاع ضغط الدم.</p><p dir="RTL">&sect;&nbsp; كلونيدين (لعلاج ارتفاع ضغط الدم أوالصداع النصفي). يجب عدم التوقف عن تناول كلونيدين إذا تناولته بالتزامن مع <strong>تنسوتين،</strong> إذا لم يخبرك طبيبك المعالج خلاف ذلك. إذا كان يجب عليك التوقف عن تناول كلونيدين، فسوف يقدم لك طبيبك المعالج الإرشادات اللازمة لتوضيح ذلك الأمر.</p><p dir="RTL">&sect;&nbsp; فيراباميل، ديلتيازيم ونيفيديبين (لعلاج ارتفاع ضغط الدم أو ألم الصدر).</p><p dir="RTL">&sect;&nbsp; ديسوبراميد، كينيدين أو أميدراون (لعلاج اضطرابات نظم ضربات القلب).</p><p dir="RTL">&sect;&nbsp; ديجوكسين (لعلاج مشاكل القلب)</p><p dir="RTL">&sect;&nbsp; أدرينالين، يعرف أيضاً باسم ايبينفرين (هو دواء يعمل على تحفيز القلب)</p><p dir="RTL">&sect;&nbsp; ليدوكائين، بروكاييناميد ونورادرينالين، كما تعرف باسم بروكاييناميد ونورادرينالين (لعلاج مشاكل القلب).</p><p dir="RTL">&sect;&nbsp; آيبوبروفين أو إندوميثاسين (لعلاج الألم والالتهاب).</p><p dir="RTL">&sect;&nbsp; انسولين أو الأدوية يتم تناولها عن طريق الفم لعلاج داء السكري.</p><p dir="RTL">&sect;&nbsp; الأدوية التي تستخدم لعلاج احتقان الأنف والجيوب الأنفية أو نزلات البرد الأخرى (بما في ذلك الأدوية التي من الممكن شراؤها من الصيدلية).</p><p dir="RTL"><strong>العمليات الجراحية</strong></p><p dir="RTL">يجب عليك إخبار طبيب التخدير أو الفريق الطبي أنك تتناول<strong> تنسوتين</strong>، إذا كنت تنوي التوجه للمستشفى لإجراء عملية جراحية.</p><p dir="RTL">ذلك لأنه قد ينخفض ضغط الدم لديك إذا تم تخديرك بأدوية معينة بالتزامن مع تناول <strong>تنسوتين.</strong></p><p dir="RTL"><strong>الحمل، الرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">&nbsp;يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعاملين معه للحصول على المشورة الطبية قبل تناول هذا الدواء، إذا كنت حاملاً، أو ترضعين طفلك رضاعة طبيعية، تعتقدين أنك حاملاً أو تخططين لإنجاب طفل.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">&sect;&nbsp; من غير المحتمل أن يؤثر الدواء على قدرتك على القيادة أو استخدام الآلات أو المعدات. على الرغم من ذلك، يفضل الانتظار لمعرفة مدى تأثير هذا الدواء عليك قبل محاولتك للقيام بمثل هذه الأنشطة.</p><p dir="RTL">&sect;&nbsp; يجب عليك عدم القيادة أو استخدام أية معدات أو آلات، إذا شعرت بدوخة أو تعب أثناء تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائماً تناول هذا الدواء بدقة وفقاً لتعليمات طبيبك المعالج أو الصيدلي الذي تتعامل معه. كما يجب عليك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه مالم تكن متاكداً من كيفية تناول هذا الدواء.</p><p dir="RTL">&sect;&nbsp; سوف يخبرك طبيبك المعالج عن عدد الأقراص الواجب عليك تناولها لكل يوم وكيفية تناولها.</p><p dir="RTL">&sect;&nbsp; قم بابتلاع أقراص <strong>تنسوتين</strong> كاملةً مع كوب من الماء.</p><p dir="RTL">&sect;&nbsp; حاول أن تتناول الأقراص في نفس الوقت من كل يوم.</p><p dir="RTL"><strong>البالغون</strong></p><p dir="RTL">سوف يقرر طبيبك المعالج مقدار الجرعة اليومية الواجب عليك تناولها من <strong>تنسوتين</strong>، وذلك اعتماداً على الحالية المرضية التي تعاني منها.</p><p dir="RTL">عادة يتم تناول الجرعة مرة واحدة في اليوم.</p><p dir="RTL">&sect;&nbsp; <strong>ارتفاع ضغط الدم</strong>: يتراوح مقدار الجرعة الموصى بها 50 ملغم إلى 100 ملغم يومياً.</p><p dir="RTL">&sect;&nbsp; <strong>ألم في الصدر (ذبحة صدرية</strong>): يتراوح مقدارالجرعة الموصى من&nbsp; 50 ملغم إلى 100 ملغم يومياً أو 50 ملغم مرتان يومياً.</p><p dir="RTL">&sect;&nbsp; <strong>عدم تكافؤ ضربات القلب (اضطرابات نظم ضربات القلب): </strong>يتراوح مقدار الجرعة الموصى بها من 50 ملغم إلى 100 ملغم يومياً.</p><p dir="RTL"><strong>&sect;&nbsp; </strong><strong>للعلاج المبكر للنوبة القلبية (احتشاء عضلة القلب): </strong>يبلغ مقدار الجرعة الموصى بها من 50 ملغم مرتان يومياً. قد يقوم طبيبك المعالج لاحقاً بتغير مقدار الجرعة إلى 100 ملغم مرة واحدة يومياً.</p><p dir="RTL"><strong>&sect;&nbsp; </strong><strong>للحد من حدوث النوبات القلبية الأخرى:</strong><strong> </strong>يبلغ مقدار الجرعة الموصى بها 100 ملغم يومياً.</p><p dir="RTL"><strong>فئة كبار السن </strong>&nbsp;</p><p dir="RTL">إذا كنت من فئة كبار السن، قد يقرر طبيبك المعالج إعطائك مقدار جرعة أقل، وبصفة خاصة إذا كنت تعاني من مشاكل في الكلى.</p><p dir="RTL"><strong>المرضى الذين يعانون من مشاكل في الكلى</strong></p><p dir="RTL">إذ كنت تعاني من مشاكل شديدة في الكلى، سوف يقرر طبيبك المعالج إعطائك مقدار جرعة أقل من <strong>تنسوتين</strong>.</p><p dir="RTL"><strong>الاستخدام من قبل الأطفال</strong></p><p dir="RTL">&nbsp;يجب عدم إعطاء هذا الدواء للأطفال.</p><p dir="RTL"><strong>إذا تناولت تنسوتين بجرعة أكبر مما يجب</strong></p><p dir="RTL">يرجى منك التحدث إلى طبيبك المعالج أو التوجه إلى المستشفى على الفور، إذا تناولت <strong>تنسوتين</strong> بجرعة أكبر من الموصى بها من قبل طبيبك المعالج، مع أخذ عبوة الدواء معك كي يمكن التحقق من الأقراص.</p><p dir="RTL"><strong>إذا سهوت عن تناول تنسوتين </strong></p><p dir="RTL">إذا سهوت عن تناول إحدى الجرعات، فيجب عليك تناولها في أقرب وقت ممكن حال تذكرها. على الرغم من ذلك، إذا اقترب موعد الجرعة التالية، فيجب عليك التخطىي عن تناول الجرعة التي قد سهوت عنها. يجب عدم تناول جرعة مضاعفة لتعويض الجرعة التي قد سهوت عن تناولها.</p><p dir="RTL"><strong>إذا توقفت عن تناول تنسوتين</strong></p><p dir="RTL">يجب عدم التوقف عن تناول <strong>تنسوتين</strong> دون استشارة طبيبك المعالج، حتى وإن كنت تشعر بتحسن. في بعض الحالات، قد تحتاج للتوقف عن تناول هذا الدواء تدريجياً. سوف يقدم لك طبيبك المعالج الإرشادت حول كيفية التوقف عن تناول هذا الدواء.</p><p dir="RTL"><strong>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا كان لديك أية أسئلة إضافية حول استخدام هذا الدواء.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يؤدي<strong> تنسوتين</strong>، إلى حدوث تأثيرات جانبية، على الرغم من ذلك فإنها قد لا تحدث لكل شخص.</p><p dir="RTL"><strong>تفاعلات تحسسية:</strong></p><p dir="RTL">يرجى منك رؤية الطبيب المعالج على الفور، إذا كنت تعاني من تفاعلات تحسسية. تتضمن العلامات على تكتلات جلدية بارزة، أو تورم الوجه، الشفتين، الفم، اللسان أو الحلق.</p><p dir="RTL"><strong>التأثيرات الجانبية المحتملة الأخرى:</strong></p><p dir="RTL"><strong>شائعة (قد تؤثرعلى ما يصل إلى شخص واحد من كل 10 أشخاص)</strong></p><p dir="RTL">&sect;&nbsp; قد تلاحظ تباطؤ في معدل ضربات القلب أثناء فترة تناول هذا الدواء. يعد ذلك طبيعياً، ولكن إذا راودك القلق يرجى منك إخبار طبيبك المعالج حول ذلك.</p><p dir="RTL">&sect;&nbsp; برودة اليدين والقدمين.</p><p dir="RTL">&sect;&nbsp; إسهال.</p><p dir="RTL">&sect;&nbsp; الشعور بالإعياء (غثيان).</p><p dir="RTL">&sect;&nbsp; الشعور بالتعب.</p><p dir="RTL"><strong>غير شائعة (قد تؤثر على ما يصل إلى شخص واحد من كل 100 شخص)</strong></p><p dir="RTL">&sect;&nbsp; اضطرابات في النوم.</p><p dir="RTL"><strong>نادرة (قد تؤثر على ما يصل إلى شخص واحد من كل 1000 شخص)</strong></p><p dir="RTL">&sect;&nbsp; احصار القلب (والذي من الممكن أن يسبب اضطرابات في نظم ضربات القلب، دوخة، إرهاق أو إغماء).</p><p dir="RTL">&sect;&nbsp; تنميل وتشنج الأصابع والذي يكون مصحوباً بألم وسخونة (ظاهرة رينود).</p><p dir="RTL">&sect;&nbsp; اضطرابات مزاجية.</p><p dir="RTL">&sect;&nbsp; أحلام مزعجة.</p><p dir="RTL">&sect;&nbsp; الشعور بالارتباك.</p><p dir="RTL">&sect;&nbsp; تغيرات في الشخصية (الذهان) أو هلوسة.</p><p dir="RTL">&sect;&nbsp; صداع.</p><p dir="RTL">&sect;&nbsp; دوخة (بصفة خاصة عند الوقوف).</p><p dir="RTL">&sect;&nbsp; تخدر في الأصابع.</p><p dir="RTL">&sect;&nbsp; عدم القدرة على الانتصاب (عجز جنسي).</p><p dir="RTL">&sect;&nbsp; جفاف الفم.</p><p dir="RTL">&sect;&nbsp; جفاف العينين</p><p dir="RTL">&sect;&nbsp; اضطرابات في الرؤية.</p><p dir="RTL">&sect;&nbsp; ضعف في الشعر</p><p dir="RTL">&sect;&nbsp; طفح جلدي</p><p dir="RTL">&sect;&nbsp; نقص في تعداد الصفائح الدموية في الدم (مما يؤدي إلى ظهور الكدمات بسهولة أكثر).</p><p dir="RTL">&sect;&nbsp; علامات أرجوانية على الجلد.</p><p dir="RTL">&sect;&nbsp; يرقان (مسببة اصفرار الجلد أو بياض العينين).</p><p dir="RTL"><strong>نادرة جداً (قد تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص)</strong></p><p dir="RTL"><strong>&sect;&nbsp; </strong>تغيرات في بعض خلايا الدم أو أجزاء أخرى من الدم. لذلك سوف يقوم طبيبك المعالج بإجراء فحص الدم كل فترة ليتحقق من مدى تأثير <strong>تنسوتين </strong>على الدم.</p><p dir="RTL"><strong>غير معروفة (لا يمكن تقدير معدل تكرار حدوثها من البيانات المتاحة)</strong></p><p dir="RTL">&sect;&nbsp; متلازمة شبيهة بداء الذئبة الحمامية (وهو مرض يحدث عندما ينتج الجهاز المناعي أجسامًا مضادة مُوجهة ضد أنسجة الجسم كالجلد والمفاصل)</p><p dir="RTL"><strong>حالات من الممكن أن تصبح أسوأ</strong></p><p dir="RTL">إذا كنت تعاني من الحالات التالية، قد تصبح أسوأ عند البدء في تناول الدواء. يحدث ذلك بصورة نادرة مؤثراً على أقل من شخص واحد من كل 1000 شخص.</p><p dir="RTL">&sect;&nbsp; الصدفية (حالة مرضية جلدية)</p><p dir="RTL">&sect;&nbsp; ضيق في التنفس أو تورم الكاحلين (إذا كنت تعاني من فشل القلب)</p><p dir="RTL">&sect;&nbsp; أزمة الربو أو مشاكل في التنفس.</p><p dir="RTL">&sect;&nbsp; ضعف الدورة الدموية</p><p dir="RTL">يجب عليك عدم القلق حول قائمة التأثيرات الجانبية المذكورة أعلاه. فقد لا تتعرض لأيٍ منها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><u>الإبلاغ عن التأثيرات الجانبية</u></strong></p><p dir="RTL">يرجى منك إخبار طبيبك المعالج، الصيدلي الذي تتعامل معه أو الممرض، في حال حدوث أياً من التأثيرات الجانبية بما في ذلك أية تأثيرات جانبية يحتمل حدوثها ولم يتم ذكرها في هذه النشرة.</p><p dir="RTL">كما يمكنك أيضا الإبلاغ عن التأثيرات الجانبية مباشرة عن طريق:</p><p dir="RTL"><strong>&sect;&nbsp; </strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL">المركز<strong> الوطني للتيقظ والسلامة الدوائية</strong></p><p dir="RTL"><strong>رقم الفاكس:&nbsp; </strong>&nbsp;7662-205-11-966+</p><p dir="RTL"><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على:</strong> 2038222-11-966+</p><p dir="RTL"><strong>وصلة</strong><strong> هاتف:</strong>2340-2356-2317</p><p dir="RTL"><strong>الخط</strong><strong> الساخن: </strong>19999</p><p dir="RTL"><strong>البريد</strong><strong> الإلكتروني:</strong><strong> </strong><strong>&nbsp;</strong>npc.drug@sfda.gov.sa</p><p dir="RTL"><strong>الموقع</strong><strong> الإلكتروني: </strong>www.sfda.gov.sa/npc</p><p dir="RTL">&sect;&nbsp; <strong>دول مجلس التعاون الخليجي الأخرى:</strong> يرجى الاتصال بالجهات المختصة ذات الصلة</p><p dir="RTL">إن تسجيل التأثيرات الجانبية يساعد في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p dir="RTL">-&nbsp; يجب عدم تناول <strong>تنسوتين</strong> بعد تاريخ انتهاء الصلاحية المذكور على العبوة والشريط.</p><p dir="RTL">-&nbsp; يحفظ في درجة حرارة أقل من 30&deg;م، في مكان جاف.</p><p dir="RTL">-&nbsp; يجب عدم تناول <strong>تنسوتين</strong> إذا لاحظت أي علامات تلف واضحة.</p><p dir="RTL">-&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي أتينولول. يحتوي كل قرص مكسو على &nbsp;100 ملغم من أتينولول.</p><p dir="RTL">المواد غير الفعالة:&nbsp; نشا الذرة، كربونات المغنيسيوم، كبريتيت لوريل الصوديوم، مسحوق سليلوز، بلورات سليلوز متناهية الصغر، غليكولات النشاء&nbsp;الصودي، ستيرات المغنيسيوم، هيبروميلوز، بولي ايثيلين جلايكول 4000، تلك، ثنائي أكسيد التيتانيوم، صبغة برتقالية وإف دي وسي أحمر رقم 40.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر <strong>تنسوتين</strong> في عبوات تحتوي كلاً منها على 30 قرصاً (3 أشرطة يحتوي كل شريط على 10أقراص) وتحتوي العبوات المخصصة للمستشفيات على 100 قرص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية&quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
17/06/2020م
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tensotin 100mg Film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film-coated tablet contains:
Item No.     Material Name	           Scale (mg/Tablet)
		
	             Active Ingredient:	
1.		     Atenolol	                               100.00
		
	            Inactive Ingredients:	
1.		    Maize starch	                       214.30
2.		    Magnesium carbonate 	       23.00
3.		    Sodium lauryl sulphate 	       4.20
4.		    Cellulose powder	               10.00
5.		    Microcrystalline cellulose    20.00
6.		    Sodium starch glycolate      26.00
7.		    Magnesium stearate 	      2.50
8.		    Purified water*	              q.s.
		
	          Coating materials 	
1.		  Hypromellose 
                  (Hydroxypropyl 
                  methylcellulose)	             12.50
2.		  Polyethylene glycol 4000     2.40
3.		  Talc fine powder 	             2.35
4.		  Titanium dioxide 	             0.70
5.		  Dispersed orange 	             2.00
6.		  FD & C Red 40 lake 	            0.05
7.		  Purified water *	                    q.s.

* It will evaporate and will not appear in the final product.

For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated Tablets
Description: Orange colour, round, bevel, biconvex film-coated tablets.
Marking: Face one: Crescent score-line 
Face two: GPI

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Tensotin </strong>is indicated in the treatment of:</p><p>&sect; Management of hypertension.</p><p>&sect; Management of angina pectoris.</p><p>&sect; Control of cardiac arrhythmias.</p><p>&sect; In early intervention in the acute phase of myocardial infarction and for long-term prophylaxis after recovery from myocardial infarction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Posology</u></strong></p><p><strong><u>Adults</u></strong></p><p><strong>Control of hypertension: </strong></p><p>Most patients respond to 50 mg daily given orally as a single dose. If necessary, the dose may be increased to 100 mg daily. The effect will be fully established after one to two weeks. A further reduction in blood pressure may be achieved by combining atenolol 25mg with other antihypertensive agents.</p><p><strong>Management of angina pectoris: </strong></p><p>Most patients with angina pectoris will respond to 100 mg daily given orally as a single dose or as 50 mg given twice a day. It is unlikely that additional benefit will be gained by increasing the dose.</p><p><strong>Control of cardiac arrhythmias: &nbsp;</strong></p><p>An oral maintenance dose of atenolol is 50&ndash;100 mg, given once daily. &nbsp;</p><p><strong>Early and late intervention after myocardial infarction: &nbsp;</strong></p><p>Oral treatment with atenolol can be initiated in haemodynamically stable patients with 50mg twice daily, and then 100 mg once daily. During the early phase of acute myocardial infarction, treatment with atenolol should be initiated in hospital under close monitoring. If bradycardia and/or hypotension requiring treatment, or any other untoward effects occur, atenolol should be discontinued. &nbsp;</p><p>Atenolol 100 mg daily is recommended for long-term prophylaxis of myocardial infarction.</p><p><strong><u>Paediatric population</u></strong></p><p>There is no paediatric experience with atenolol and for this reason it is not recommended for use in children.</p><p><strong><u>Elderly&nbsp;&nbsp; </u></strong></p><p>Dosage requirements may be reduced, especially in patients with impaired renal function.</p><p><strong>Renal impairment </strong></p><p>Since atenolol is excreted via the kidneys, the dosage should be adjusted in cases of severe impairment of renal function.</p><p>No significant accumulation of atenolol occurs in patients who have a creatinine clearance greater than 35 ml/min/1.73 m<sup>2 </sup>(normal range is 100&ndash;150 ml/min/1.73 m<sup>2</sup>).</p><p>For patients with a creatinine clearance of 15&ndash;35 ml/min/1.73 m<sup>2</sup>&nbsp;(equivalent to serum creatinine of 300&ndash;600 micromol/litre), the dose should be 50 mg daily.</p><p>For patients with a creatinine clearance of less than 15 ml/min/1.73 m<sup>2</sup>&nbsp;(equivalent to serum creatinine of greater than 600 micromol/litre), the dose should be 25 mg daily or 50mg on alternate days.</p><p>Patients on haemodialysis should be given 50 mg after each dialysis; this should be done under hospital supervision as marked falls in blood pressure can occur.</p><p><strong><u>Method of administration</u></strong></p><p>For administration by the oral route.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Atenolol, as with other beta-blockers, should not be used in patients with any of the following:
	hypersensitivity to the active substance, or to any of the excipients listed in section 6.1
	cardiogenic shock
	uncontrolled heart failure
	sick sinus syndrome
	second-or third-degree heart block
	untreated phaeochromocytoma
	metabolic acidosis
	bradycardia (<45 bpm)
	hypotension
	severe peripheral arterial circulatory disturbances.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Atenolol as with other beta-blockers:</p><p>&sect; Should not be withdrawn abruptly. The dosage should be withdrawn gradually over a period of 7&ndash;14 days, to facilitate a reduction in beta-blocker dosage. Patients should be followed during withdrawal, especially those with ischaemic heart disease.</p><p>&sect; When a patient is scheduled for surgery, and a decision is made to discontinue beta-blocker therapy, this should be done at least 24 hours prior to the procedure. The risk-benefit assessment of stopping beta-blockade should be made for each patient. If treatment is continued, an anaesthetic with little negative inotropic activity should be selected to minimise the risk of myocardial depression. The patient may be protected against vagal reactions by intravenous administration of atropine.</p><p>&sect; Although contraindicated in uncontrolled heart failure (see section 4.3), may be used in patients whose signs of heart failure have been controlled. Caution must be exercised in patients whose cardiac reserve is poor.</p><p>&sect; May increase the number and duration of angina attacks in patients with Prinzmetal&#39;s angina due to unopposed alpha-receptor mediated coronary artery vasoconstriction. Atenolol is a beta<sub>1</sub>-selective beta-blocker; consequently, its use may be considered although utmost caution must be exercised.</p><p>&sect; Although contraindicated in severe peripheral arterial circulatory disturbances (see section 4.3), may also aggravate less severe peripheral arterial circulatory disturbances.</p><p>&sect; Due to its negative effect on conduction time, caution must be exercised if it is given to patients with first-degree heart block.</p><p>&sect; May mask the symptoms of hypoglycaemia, in particular, tachycardia.</p><p>&sect; May mask the signs of thyrotoxicosis.</p><p>&sect; Will reduce heart rate as a result of its pharmacological action. In the rare instances when a treated patient develops symptoms which may be attributable to a slow heart rate and the pulse rate drops to less than 50&ndash;55 bpm at rest, the dose should be reduced.</p><p>&sect; May cause a more severe reaction to a variety of allergens when given to patients with a history of anaphylactic reaction to such allergens. Such patients may be unresponsive to the usual doses of adrenaline (epinephrine) used to treat the allergic reactions.</p><p>&sect; May cause a hypersensitivity reaction including angioedema and urticaria.</p><p>&sect; May cause an increase in airways resistance in asthmatic patients. Atenolol is a beta1-selective beta-blocker; consequently its use may be considered although utmost caution must be exercised. If increased airways resistance does occur, Atenolol should be discontinued and bronchodilator therapy (e.g. salbutamol) administered if necessary.</p><p>&sect; Should only be given to patients with psoriasis after careful consideration, as psoriasis may be aggravated.</p><p>Since Atenolol is excreted via the kidneys, dosage should be reduced in patients with a creatinine clearance of below 35 ml/min/1.73 m<sup>2</sup>.</p><p>As with other beta-blockers, in patients with a phaeochromocytoma, an alpha-blocker should be given concomitantly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Adrenergic neurone-blocking agents </strong></p><p>Adrenergic neurone-blocking agents such as guanethidine, reserpine, diuretics and antihypertensive agents, including the vasodilator group, will have an additive effect on the hypotensive action of the drug.</p><p><strong>Anaesthetic agents </strong></p><p>Caution must be exercised when using anaesthetic agents with Atenolol. The anaesthetist should be informed and the choice of anaesthetic should be an agent with as little negative inotropic activity as possible. Use of beta-blockers with anaesthetic drugs may result in attenuation of the reflex tachycardia and increase the risk of hypotension. Anaesthetic agents causing myocardial depression are best avoided.</p><p><strong>Antiarrhythmic agents (Class 1) </strong></p><p>Class I anti-arrhythmic drugs (e.g. disopyramide) and amiodarone may have a potentiating effect on atrial-conduction time and induce negative inotropic effect.</p><p><strong>Calcium channel blockers </strong></p><p>Combined use of beta-blockers and calcium channel blockers with negative inotropic effects, e.g. verapamil or diltiazem, can lead to an exaggeration of these effects particularly in patients with impaired ventricular function and/or sinoatrial or atrioventricular conduction abnormalities. This may result in severe hypotension, bradycardia and cardiac failure. Neither the beta-blocker nor the calcium channel blocker should be administered intravenously within 48 hours of discontinuing the other.</p><p><strong>Clonidine </strong></p><p>Beta-blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine. If the two drugs are co-administered, the beta-blocker should be withdrawn several days before discontinuing clonidine. If replacing clonidine by beta-blocker therapy, the introduction of beta-blockers should be delayed for several days after clonidine administration has stopped. (See also prescribing information for clonidine).</p><p><strong>Digitalis glycosides </strong></p><p>Digitalis glycosides, in association with beta-blockers, may increase atrioventricular conduction time.</p><p><strong>Dihydropyridines </strong></p><p>Concomitant therapy with dihydropyridines, e.g. nifedipine, may increase the risk of hypotension, and cardiac failure may occur in patients with latent cardiac insufficiency.</p><p><strong>Insulin and oral antidiabetic drugs </strong></p><p>Concomitant use with insulin and oral antidiabetic drugs may lead to the intensification of the blood sugar lowering effects of these drugs. Symptoms of hypoglycaemia, particularly tachycardia, may be masked (See Section 4.4).</p><p><strong>Myocardial depressants </strong></p><p>The beta-blocker should only be used with caution in patients who are receiving concomitant myocardial depressants such as halogenated anaesthetics, lidocaine, procainamide and beta-adrenoceptor stimulants such as noradrenaline (norepinephrine).</p><p><strong>Prostaglandin synthetase-inhibiting drugs </strong></p><p>Concomitant use of prostaglandin synthetase-inhibiting drugs, e.g. ibuprofen, indometacin, may decrease the hypotensive effects of beta-blockers.</p><p><strong>Sympathomimetic agents </strong></p><p>Concomitant use of sympathomimetic agents, e.g. adrenaline (epinephrine), may counteract the effect of beta-blockers.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Caution should be exercised when Atenolol is administered during pregnancy or to a woman who is breast-feeding.</p><p><strong><u>Pregnancy</u></strong></p><p>Atenolol crosses the placental barrier and appears in the cord blood. No studies have been performed on the use of Atenolol in the first trimester and the possibility of foetal injury cannot be excluded. Atenolol has been used under close supervision for the treatment of hypertension in the third trimester. Administration of Atenolol to pregnant women in the management of mild to moderate hypertension has been associated with intra-uterine growth retardation.</p><p>The use of Atenolol in women who are, or may become, pregnant requires that the anticipated benefit be weighed against the possible risks, particularly in the first and second trimesters.</p><p><strong><u>Breast-feeding</u></strong></p><p>There is significant accumulation of Atenolol in breast milk.</p><p>Neonates born to mothers who are receiving Atenolol at parturition or breast-feeding may be at risk of hypoglycaemia and bradycardia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Atenolol has no or negligible influence on the ability to drive and use machines. However, it should be taken into account that occasionally dizziness or fatigue may occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Atenolol is well tolerated. In clinical studies, the undesired events reported are usually attributable to the pharmacological actions of atenolol.</p><p><strong><u>Tabulated list of adverse reactions</u></strong></p><p>The following undesired events, listed by body system, have been reported with the following frequencies: very common (&ge;1/10), common (&ge;1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000) including isolated reports, not known (cannot be estimated from the available data).</p><table border="1" cellspacing="0" cellpadding="0" style="width:528px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td><td style="vertical-align:top"><p><strong>Undesirable Effect</strong></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Purpura, thrombocytopenia</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Sleep disturbances of the type noted with other beta-blockers</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Mood changes, nightmares, confusion, psychoses and hallucinations</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Dizziness, headache, paraesthesia</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Dry eyes, visual disturbances</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Bradycardia</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Heart failure deterioration, precipitation of heart block</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Cold extremities</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Postural hypotension which may be associated with syncope, intermittent claudication may be increased if already present, in susceptible patients Raynaud&#39;s phenomenon</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Bronchospasm may occur in patients with bronchial asthma or a history of asthmatic complaints</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Gastrointestinal disturbances</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Dry mouth</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Hepatic toxicity including intrahepatic cholestasis</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Alopecia, psoriasiform skin reactions, exacerbation of psoriasis, skin rashes</p></td></tr><tr><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions, including angioedema and urticaria</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Lupus-like syndrome</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Impotence</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Fatigue</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Elevation of transaminase</p></td></tr><tr><td style="vertical-align:top"><p>Very rare</p></td><td style="vertical-align:top"><p>An increase in ANA (Antinuclear Antibodies) has been observed, however the clinical relevance of this is not clear</p></td></tr></tbody></table><p>Discontinuance of the drug should be considered if, according to clinical judgement, the well-being of the patient is adversely affected by any of the above reactions.</p><p><strong><u>To report any side effect(s):</u></strong></p><p>&sect; <strong>Saudi Arabia:</strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax: </strong>+966-11-205-7662</p><p><strong>Call NPC at </strong>+966-11-2038222,&nbsp; <strong>Exts: </strong>2317-2356-2340</p><p><strong>Reporting Hotline: </strong>19999</p><p><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>Website: </strong>www.sfda.gov.sa/npc</p><p>&sect; <strong>Other GCC States: </strong>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The symptoms of overdosage may include bradycardia, hypotension, acute cardiac insufficiency and bronchospasm.</p><p><strong>General treatment should include: </strong>close supervision; treatment in an intensive care ward; the use of gastric lavage; activated charcoal and a laxative to prevent absorption of any drug still present in the gastrointestinal tract; the use of plasma or plasma substitutes to treat hypotension and shock. The possible uses of haemodialysis or haemoperfusion may be considered.</p><p>Excessive bradycardia can be countered with atropine 1&ndash;2 mg intravenously and/or a cardiac pacemaker. If necessary, this may be followed by a bolus dose of glucagon 10 mg intravenously. If required, this may be repeated or followed by an intravenous infusion of glucagon 1&ndash;10 mg/hour depending on response. If no response to glucagon occurs or if glucagon is unavailable, a beta-adrenoceptor stimulant such as dobutamine 2.5 to 10 micrograms/kg/minute by intravenous infusion may be given. Dobutamine, because of its positive inotropic effect could also be used to treat hypotension and acute cardiac insufficiency. It is likely that these doses would be inadequate to reverse the cardiac effects of beta-blocker blockade if a large overdose has been taken. The dose of dobutamine should therefore be increased if necessary to achieve the required response according to the clinical condition of the patient.</p><p>Bronchospasm can usually be reversed by bronchodilators.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group: </strong>Beta-blocking agents, plain, selective,</p><p><strong>ATC code: </strong>CO7A B03.</p><p><strong><u>Mechanism of action</u></strong></p><p>Atenolol is a beta-blocker which is beta<sub>1</sub>-selective (i.e. acts preferentially on beta<sub>1</sub>-adrenergic receptors in the heart).&nbsp; Selectivity decreases with increasing dose.</p><p>Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects (and is therefore contraindicated in uncontrolled heart failure).As with other beta-blockers, the mode of action of atenolol in the treatment of hypertension is unclear. It is probably the action of atenolol in reducing cardiac rate and contractility which makes it effective in eliminating or reducing the symptoms of patients with angina. It is unlikely that any additional ancillary properties possessed by S (-) atenolol, in comparison with the racemic mixture, will give rise to different therapeutic effects.</p><p><strong><u>Clinical efficacy and safety </u></strong></p><p>Atenolol is effective and well tolerated in most ethnic populations although the response may be less in black patients.</p><p>Atenolol is effective for at least 24 hours after a single oral dose. The drug facilitates compliance by its acceptability to patients and simplicity of dosing.</p><p>Atenolol is compatible with diuretics, other antihypertensive agents and antianginal agents (see section 4.5).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Absorption of atenolol following oral dosing is consistent but incomplete (approximately 40&ndash;50%) with peak plasma concentrations occurring 2&ndash;4 hours after dosing. The atenolol blood levels are consistent and subject to little variability. There is no significant hepatic metabolism of atenolol and more than 90% of that absorbed reaches the systemic circulation unaltered.</p><p><strong><u>Distribution</u></strong></p><p>Atenolol penetrates tissues poorly due to its low lipid solubility and its concentration in brain tissue is low. Plasma protein binding is low (approximately 3%).</p><p><strong><u>Elimination</u></strong></p><p>The plasma half-life is about 6 hours but this may rise in severe renal impairment since the kidney is the major route of elimination.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Atenolol is a drug on which extensive clinical experience has been obtained. Relevant information for the prescriber is provided elsewhere in the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:534px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Inactive Ingredients:</u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maize starch</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium carbonate</p></td></tr><tr><td style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium lauryl sulphate</p></td></tr><tr><td style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cellulose powder</p></td></tr><tr><td style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Microcrystalline cellulose</p></td></tr><tr><td style="vertical-align:top"><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium starch glycolate</p></td></tr><tr><td style="vertical-align:top"><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate</p></td></tr><tr><td style="vertical-align:top"><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified water*</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Coating materials </u></strong></p></td></tr><tr><td style="vertical-align:top"><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypromellose (Hydroxypropyl methylcellulose)</p></td></tr><tr><td style="vertical-align:top"><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Polyethylene glycol 4000</p></td></tr><tr><td style="vertical-align:top"><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Talc fine powder</p></td></tr><tr><td style="vertical-align:top"><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Titanium dioxide</p></td></tr><tr><td style="vertical-align:top"><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dispersed orange</p></td></tr><tr><td style="vertical-align:top"><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; FD &amp; C Red 40 lake</p></td></tr><tr><td style="vertical-align:top"><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purified water *</p></td></tr></tbody></table><p>* It will evaporate and will not appear in the final product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, in a dry place</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pack of 30 Tablets: </strong>3x10&rsquo;s Tablets in an aluminium PVC film PVDC coated blister, packed in a printed carton along with a leaflet.</p><p><strong>Pack of 100 Tablets: </strong>10x10&rsquo;s Tablets in an aluminium PVC film PVDC coated blister, packed in a printed carton along with a leaflet.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street
Ras Al Khaimah - United Arab Emirates
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                17. June. 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>